Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeuroKit versus NeuroCart validation with lorazepam, modafinil, and S-ketamine
NL-OMON57507Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lorazepam, modafinil and esketamine (4 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Saccadic eye movement, Smooth pursuit eye movement and 7 more. Started Apr 2025; status: completed.
02
Drugs
lorazepammodafinilesketamine
Beyond the preview
Go deeper on NL-OMON57507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57507.